47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,5 | -0,5 | -0,4 | 8,3 |
Gross profit (loss) | -0,7 | -0,8 | -1 | -25,5 |
EBITDA | -0,6 | -0,6 | -0,6 | 1 |
Short time liabilities | 3 | 4,1 | 18,3 | 347,6 |
Other operating costs | 0,1 | 0,2 | 0,2 | 7,8 |
Equity capital | -1,6 | -2,4 | -3,4 | -41,1 |
Operating profit (EBIT) | -0,6 | -0,6 | -0,6 | 1,8 |
Assets | 1,4 | 1,8 | 15 | 727,7 |
Net profit (loss) | -0,7 | -0,8 | -1 | -23,3 |
Cash | 0 | 0 | 0 | 8,1 |
Net income from sale | 7 | 7,3 | 8,8 | 19,4 |
Liabilities and provisions for liabilities | 3,1 | 4,2 | 18,4 | 335,6 |
Working assets | 1,1 | 1,6 | 1,8 | 14,1 |
Other income costs | 0 | 0 | 0 | -42,7 |
Depreciation | 0,1 | 0 | 0 | -13,7 |
% | % | % | p.p. | |
Profitability of capital | 43,1 | 33,3 | 29,1 | -4,2 |
Equity capital to total assets | -111,2 | -133,1 | -22,7 | 110,4 |
Gross profit margin | -10 | -10,9 | -11,5 | -0,6 |
EBITDA Margin | -8,5 | -8 | -6,6 | 1,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 156 | 203 | 760 | 557 |
Current financial liquidity indicator | 0.3831128180027008 | 0.3956690728664398 | 0.10086171329021454 | -0,3 |
Net dept to EBITDA | 0.03347046300768852 | 0.037321966141462326 | 0.04071985185146332 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane